GSE210605
MAF Amplification licenses Estrogen Receptor a to Drive Breast Cancer Metastasis [MAF ChIP-seq]
We performed genome-wide mapping of MAF binding sites in control and MAF-overexpressing MCF7 cells to assess the consequences of estrogen (E2) stimulation on MAF recruitment to chromatin. To this end, we cultured MCF7 cells in hormone-deprived (HD) medium for 72 h and then E2 or vehicle was added for 1h prior to chromatin immunoprecipitation (ChIP). Samples were generated in triplicate. We report that MAF binding is largely independent of E2 Overall design: Examination of MAF binding sites in control and MAF-overexpressing MCF7 cells before and after E2 stimulation.